Core Points - Hanbang Technology's stock price decreased by 1.76% on November 17, with a trading volume of 42.3962 million yuan [1] - The company recorded a net financing purchase of 1.1831 million yuan on the same day, with a total financing balance of 80.224 million yuan, accounting for 10.58% of its market capitalization [1] - As of September 30, the company achieved a revenue of 506 million yuan, representing a year-on-year growth of 4.61%, while the net profit attributable to shareholders decreased by 17.27% to 37.0172 million yuan [2] Financing and Trading Data - On November 17, Hanbang Technology had a financing buy amount of 2.7984 million yuan and a financing repayment of 1.6154 million yuan [1] - The company had no short selling activity on November 17, with a short selling balance of 0 [1] - The total number of shareholders as of September 30 was 8,687, a decrease of 7.31% from the previous period [2] Business Overview - Hanbang Technology, established on October 28, 1998, specializes in providing separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [1] - The revenue composition of the company includes 70.99% from small molecule drug separation and purification equipment, 22.94% from large molecule drug separation and purification equipment, and 6.07% from other sources [1] - The company has distributed a total of 8.8 million yuan in dividends since its A-share listing [3]
汉邦科技11月17日获融资买入279.84万元，融资余额8022.40万元